Regulus Therapeutics Inc. Soared
Tue, Mar 12, 2024 at 07:22 PM
Regulus Therapeutics Inc. (RGLS:NASDAQ) jumped higher at $2.36, representing a gain of 71%. On Tue, Mar 12, 2024, RGLS:NASDAQ hit a New 2-Week High of $2.36. The stock got featured on our News Catalysts scanner on Tue, Mar 12, 2024 at 07:53 AM in the 'BIOTECH' category. From Tue, Feb 27, 2024, the stock recorded 30.00% Up Days and 54.55% Green Days
The stock spiked on Tue, Mar 12, 2024 at $3.79 with a volume of 167M+.
About Regulus Therapeutics Inc. (RGLS:NASDAQ)
Regulus Therapeutics Inc is a biotechnology company that focuses on the development of microRNA therapies. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome.
Top 10 Gainers:
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 494.06%
- ClearOne, Inc. (CLRO:NASDAQ), 127.5%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- HNR Acquisition Corp (HNRA:NYSEMKT), 121.21%
- Regulus Therapeutics Inc. (RGLS:NASDAQ), 71.01%
- Ranpak Holdings Corp. (PACK:NYSE), 51.72%
- Li-Cycle Holdings Corp. (LICY:NYSE), 46.32%
- Bright Green Corporation (BGXX:NASDAQ), 45.72%
- Semilux International Ltd. (SELX:NASDAQ), 38.5%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 34.48%